Healthcare Economics in HIV

In an era of cost-consciousness in the delivery of medical care, the economics of healthcare delivery for HIV-infected persons has been an area of active interest. Interested parties include the payors of HIV care, particularly public insurers, who are paying for an increasing amount of the overall cost of HIV care in the US; providers of care, many of whom are finding it increasingly difficult to provide HIV care in a capitated market; and those persons who are HIV-infected and increasingly caught in the economic turmoil of the HIV healthcare marketplace. This paper will review the literature published over the past year regarding the economics of healthcare for HIV in the US.